
Animate Biosciences uses AI and multi-omic data to target fibrosis with peptide-based therapies. The company builds a platform that designs and optimizes peptide candidates to halt or reduce fibrosis in human cells. Core tech includes AI-driven design, multi-omic insights, and preclinical evaluation workflows. Its focus is a B2B biotech platform serving biotech and pharma research teams. The company aims to scale with a pipeline of lead candidates across multiple fibrotic indications.

Animate Biosciences uses AI and multi-omic data to target fibrosis with peptide-based therapies. The company builds a platform that designs and optimizes peptide candidates to halt or reduce fibrosis in human cells. Core tech includes AI-driven design, multi-omic insights, and preclinical evaluation workflows. Its focus is a B2B biotech platform serving biotech and pharma research teams. The company aims to scale with a pipeline of lead candidates across multiple fibrotic indications.